By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Blueprint Medicines 



Cambridge  Massachusetts  02140  U.S.A.
Phone: 617-585-2033 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Blueprint Medicines (BPMC) Announces Closing Of Public Offering And Full Exercise Of Option To Purchase Additional Shares Of Common Stock 4/5/2017 6:51:46 AM
Blueprint Medicines (BPMC) Announces Proposed Public Offering Of Shares of Common Stock 3/29/2017 8:39:52 AM
Blueprint Medicines (BPMC) Announces Enrollment Of First Patient In Phase 1 Clinical Trial For BLU-667 3/21/2017 6:32:21 AM
Blueprint Medicines (BPMC) Reports Fourth Quarter And Full Year 2016 Financial Results 3/9/2017 11:12:09 AM
Blueprint Medicines (BPMC) To Report Fourth Quarter And Full Year 2016 Financial Results On Thursday, March 9, 2017 3/2/2017 9:45:50 AM
Chris Varma, Co-Founder And Former President And CEO Of Blueprint Medicines (BPMC), Joins MPM Capital As Entrepreneur-In-Residence 2/7/2017 8:12:57 AM
Blueprint Medicines (BPMC) Announces Closing Of Public Offering And Full Exercise Of Option To Purchase Additional Shares Of Common Stock 12/14/2016 6:45:03 AM
Blueprint Medicines (BPMC) Announces Pricing Of Public Offering Of Shares Of Common Stock 12/8/2016 8:46:43 AM
Blueprint Medicines (BPMC) Announces Proposed Public Offering Of Shares Of Common Stock 12/7/2016 7:03:21 AM
Blueprint Medicines (BPMC) Announces Proof-Of-Concept Data From Phase 1 Clinical Trial Of BLU-285 In Patients With Advanced Systemic Mastocytosis 12/5/2016 6:32:39 AM
123456789
//-->